BioMagnetic Solutions LLC

General information

Founded in 2011, by Paul A. Liberti, BioMagnetic Solutions provides cutting-edge Ferrofluids (nano magnetic liquids) and path-breaking novel multi-parameter magnetic separator systems to the life sciences. Having pioneered the development of Ferrofluids and the design and manufacture of novel magnetic platform technologies for biological separations from its Immunicon (developer of CellSearch©) lineage, BioMagnetic Solutions’ scientists and engineers provide cutting-edge proprietary immuno-magnetic separation systems for world-class biopharma and life science firms. BioMagnetic Solutions is developing a highly novel circulating tumor cells (CTC) platform leveraging BioMagnetic Solutions' 5th generation ferrofluids and proprietary front-end isolation technology for superior, rapid, rare cell capture and downstream characterization. BMS' system utilizes principles of magnetic manipulation never previously applied to cells. BioMagnetic Solutions is also developing a large-scale clinical cell separator for immunotherapeutic approaches for CAR-T, Byte, TCR, TIL and immuno-oncology applications. BioMagnetic Solutions partners with world-class biopharma firms to solve important problems for major cell therapy, rare cell and immuno-magnetic cell separations. BMS’ life science academic research roots and commitment to serving life science researchers run deep. We serve the research community via select ongoing collaborations with top tier researchers and our research products...